Nucleix
Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
About
Nucleix is a liquid biopsy company focused on revolutionizing cancer treatment through earlier disease detection. They leverage NGS-based and PCR-based technology to identify methylation changes, offering a pioneering testing approach that aims to detect cancer at a stage where intervention can have the greatest impact for patients. Teams look it up for Healthcare, Lung, Bladder.
Frequently asked
What does Nucleix do?
Nucleix is a Healthcare company that offers Software. Teams look it up for Lung, Bladder, Cancer. It is based in Rehovot, Israel and was founded in 2008. Public records show about 74 people and $88M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Nucleix raised?
Nucleix has raised a total of $88M in funding. The most recent round on record is Funding Round.
Where is Nucleix headquartered?
Nucleix is headquartered in Rehovot, Israel.
When was Nucleix founded?
Nucleix was founded in 2008.
What industry does Nucleix operate in?
Nucleix operates in Healthcare, Lung, Bladder, Cancer, Diagnostics.
How many employees does Nucleix have?
Nucleix has approximately 74 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
“Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx.”
View on Reddit“D'après des experts européens de premier plan dans le domaine du cancer de la vessie, le test d'urine Bladder EpiCheck de Nucleix peut réduire les procédures invasives.”
View on Reddit“Führende europäische Blasenkrebsexperten: der Urintest Bladder EpiCheck von Nucleix kann invasive Verfahren reduzieren.”
View on Reddit“I principali esperti europei del cancro alla vescica dichiarano: il test delle urine Bladder EpiCheck di Nucleix può ridurre le procedure invasive.”
View on Reddit“El Nucleix Bladder EpiCheck Urine Test puede reducir los procedimientos invasivos.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.